Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

September 24, 2018 07:00 ET | Source: NeoGenomics, Inc.

NeoGenomics Announces Participation in NCI-MATCH Clinical Trial

FT. MYERS, Fla., Sept. 24, 2018 (GLOBE NEWSWIRE) -- NeoGenomics Laboratories, Inc. (NASDAQ: NEO), a leading provider of cancer-focused genetic testing services, announced today that it is...
September 12, 2018 08:14 ET | Source: NeoGenomics, Inc.

NeoGenomics Awarded Clinical Reference Laboratory Testing Services Agreement with Premier

FT. MYERS, Fla., Sept. 12, 2018 (GLOBE NEWSWIRE) -- NeoGenomics, Inc. (NASDAQ: NEO), a leading provider of cancer-focused genetic testing services, announced today that it has been awarded a group...
August 09, 2018 20:40 ET | Source: NeoGenomics, Inc.

NeoGenomics Announces Pricing on Public Offering of Common Stock

FT. MYERS, Fla., Aug. 09, 2018 (GLOBE NEWSWIRE) -- NeoGenomics, Inc. (NASDAQ: NEO), a leading provider of cancer-focused genetic testing services, today announced the pricing of its underwritten...
August 06, 2018 16:19 ET | Source: NeoGenomics, Inc.

NeoGenomics Announces Proposed Public Offering of Common Stock

FT. MYERS, Fla., Aug. 06, 2018 (GLOBE NEWSWIRE) -- NeoGenomics, Inc. (NASDAQ: NEO), a leading provider of cancer-focused genetic testing services, announced today that it has commenced an...
July 24, 2018 07:00 ET | Source: NeoGenomics, Inc.

NeoGenomics Reports Record Revenue of $67.7 Million with 14% Increase in Clinical Volume Growth and 95% Increase in Pharma Services Backlog

The Company adopted ASC 606, effective January 1, 2018, using the full retrospective method of adoption. Unless otherwise indicated, all financial results have been restated as if the Company had...
July 02, 2018 16:05 ET | Source: NeoGenomics, Inc.

NeoGenomics Schedules its Second Quarter Earnings Release for July 24, 2018

FT. MYERS, Fla., July 02, 2018 (GLOBE NEWSWIRE) -- NeoGenomics, Inc. (NASDAQ:NEO), a leading provider of cancer-focused genetic testing services, announced today that it plans to release its second...
June 25, 2018 16:05 ET | Source: NeoGenomics, Inc.

NeoGenomics Redeems 100% of Series A Redeemable Preferred Stock

Closes on $30 Million Extension to Senior Credit Facility FT. MYERS, Fla., June 25, 2018 (GLOBE NEWSWIRE) -- NeoGenomics, Inc. (NASDAQ:NEO) (the “Company”), a leading provider of cancer-focused...
June 01, 2018 08:00 ET | Source: NeoGenomics, Inc.

PPD and NeoGenomics Forming Global Strategic Alliance for Pathology and Molecular Testing Solutions

Expanding global oncology testing for clinical trials WILMINGTON, N.C., June 01, 2018 (GLOBE NEWSWIRE) -- Pharmaceutical Product Development, LLC (PPD), a leading global contract research...
May 25, 2018 16:05 ET | Source: NeoGenomics, Inc.

NeoGenomics to Participate In Two Upcoming Investor Conferences

FT. MYERS, Fla., May 25, 2018 (GLOBE NEWSWIRE) -- NeoGenomics, Inc. (NASDAQ:NEO), a leading provider of cancer-focused genetic testing services, today announced that company management will be...